Sleep and aging

Sleep Disorders

Updated 08.01.2023
Released 04.07.2020
Expires For CME 08.01.2026

Sleep and aging

Authors: Biancamaria Guarnieri MD, Ilde Pieroni MSc

See Contributor Disclosures

Editor: Federica Provini MD

Sleep and aging

In This Article

Quick Link

Introduction

Overview

This article aims to focus on aspects the authors consider relevant for clinical practice and future research directions and not to give a complete review of all aspects of sleep and aging. As the world population ages, the aging population is rapidly changing. The “feminization of aging” implies a more in-depth attention to sex and gender differences. Additionally, there are important differences among younger-old and older-old persons, with sex specificities. New lifestyles, work, and familial and social habits can greatly alter circadian rhythms, even in elderly persons.

In the last 2 decades, sleep deficiency and hypersomnolence have become important concerns of everyday life. These problems have a “human impact” (44), a relatively new concept that is a synthesis between health and social impact. This concept can apply to environmental and climate problems and can be used to develop programs and human health and welfare decisions.

Moreover, new environmental problems interfere with sleep and aging, such as reduced daytime exposure to sunlight and more light pollution in our towns at night. These phenomena are attracting growing interest from sleep and public health researchers worldwide.

In aging, “subjective” and “objective” sleep characteristics show several differences between men and women. Such aspects need to be deeply investigated for tailoring diagnostic and therapeutic interventions according to sex and gender. Studies have focused on the relationship between sleep and the preclinical phases of neurodegenerative diseases and dementia. Sleep disturbances may be present at the earliest stages of neurodegeneration or neuroinflammation: growing epidemiological data have demonstrated that sleep disturbances can be considered a risk factor for dementia. Greater attention to sleep since midlife and among older adults can offer new opportunities for multidomain interventions to prevent neurodegenerative disorders and other chronic conditions.

Key points

	• The aging population is rapidly changing: there are new difficulties in defining old persons as a homogeneous group and in assessing related sleep and sleep-wake rhythm characteristics and disorders.
	• Sleep and circadian sleep-wake rhythms change in older adults.
	• A new research agenda on excessive daytime sleepiness, sleep deficiency, environmental problems, work and family demands interfering with sleep habits, and the global impact on older adults is discussed.
	• The relevance of the timing of risk factors for growing epidemiological data on sleep, aging, and cognitive decline is reviewed.
	• Sex differences in some aspects of sleep among older adults are discussed; unmet needs regarding gender differences are proposed as a future, relevant direction of sleep research.

Historical note and terminology

Since the late 1990s, many researchers have demonstrated that sleep characteristics, sleep, and sleep-wake rhythm disturbances are important in the aging process. They cannot be considered a mere and inevitable consequence of aging, as persons aged 65 years and over are a heterogeneous group. Increasing sleep debt in middle and advanced age and excessive daytime sleepiness are under new investigation and should be emphasized and deeply elucidated for specific interventions.

In aging, insomnia or drowsiness, collectively referred to as sleep complaints, are frequent and associated with relevant concurrent morbidities. Primary sleep disturbances are highly prevalent in older adults (84; 118). In the elderly, sleep disturbances can share unconventional presentations among older adults with possible delays in their assessment and management. Sleep disturbances are frequent in several forms of dementia and in mild cognitive impairment, with percentages exceeding 40%, and two or more disturbances are often present in the same patient (49). Dementia research has shown that brain pathological alterations can precede the clinical onset of cognitive decline by several decades. In 2011, the diagnostic criteria for Alzheimer disease introduced a preclinical phase of the disease defined by specific biomarkers (76). Growing evidence demonstrates that sleep disturbances can be considered an independent risk factor for neurodegeneration in a bidirectional or circular relationship (59; 52).

Clinical manifestations

Presentation and course

Sleep changes in aging persons. Sleep changes with aging (33; 28; 65). Understanding the determinants of these changes is essential for both health and social domains. Sleep duration and distribution within a 24-hour period are influenced by environmental (eg, artificial lighting) and genetic (eg, sex) factors. Numerous studies have demonstrated that age plays a significant role in explaining the variability of sleep duration in the general population, with younger adults tending to sleep less than older individuals due to factors such as childcare and work demands. A large-scale study indicates that sleep duration varies across different nations and is influenced by geographical factors such as latitude (26). The study showed that different countries worldwide exhibit distinct phases of life characterized by differences in sleep duration. The average amount of sleep per person worldwide was 7.01 hours, women generally slept 7.5 minutes longer than men, and three unique phases were identified across the life course. The authors discovered a relevant decline in sleep duration for both men and women from early adulthood to 35 years. The average reported sleep duration then started to rise again until the age of 70 years, when it reached the same value as seen at the age of 30 for men and 25 for women (women = 7.0 hours, men = 7.1 hours). The reduction slowed and plateaued until the age of 50 (women = 6.9 hours, men = 6.8 hours) (26). It is important to better combine earlier and newer data on sleep length regarding sleep duration in aging according to new lifestyles and work and social demands.

Along normal aging the macrostructure of sleep changes. Total sleep time, sleep efficiency, slow wave sleep, and REM sleep decrease, whereas the number of awakenings and the duration of time awake during the night increase, as described in a large meta-analysis from 65 studies (polysomnography - actigraphy) on 3577 healthy persons between 5 and 102 years of age (86). Two meta-analyses confirmed a linear decrease of total sleep time with aging (10-12 minutes per decade), but this reduction was not clearly detected after 60 years of age, indicating a plateau in this period of life (37). A laboratory study on 50 healthy adults between 19 and 81 years of age demonstrated that, considering spontaneous sleep over the 24 hours, older adults had significantly reduced nighttime sleep duration (8.1 hours) as compared to middle-aged (9.1 hours) and young (10.5 hours) adults (17).

Sleep initiation, the ability to reinitiate sleep after nocturnal awakenings, and sleep maintenance remain substantially unchanged after the age of 60 years. Conversely, a slow decline in sleep efficiency has been detected with advancing age (86; 33).

In general, in healthy aging, slow wave and REM sleep decrease while stage 1 and stage 2 increase but without significant differences as compared to young adults. Also, the reduction in REM sleep latency has not demonstrated significant changes: a linear, only 0.6% per decade decrease has been observed until 75 years of age whereas a small increase was found between 75 and 85 years (37). Often, REM sleep alterations only emerge as a symptom of degenerative dementia (67; 15). Even the microstructure of sleep, including the quality and quantity of sleep oscillations (micro arousals), changes with aging (75).

It is not always easy to define a complete health status in the elderly, considering also the possibility of preclinical and prodromal phases of neurodegenerative disorders, particularly Alzheimer disease (52).

A worse health status is often attributable to an increase in chronic conditions, cognitive decline, and medication use, which can precipitate insomnia or excessive daytime sleepiness.

In the National Sleep Foundation’s 2003 poll, 71% of those who rated their health status as fair-to-poor reported insomnia, and 29% reported drowsiness. The Established Populations for Epidemiologic Studies of the Elderly found a self-reported fair-to-poor health status in 36% of community-dwelling persons aged 65 years or older, and it was significantly associated with insomnia symptoms (40).

A relevant topic has not yet been completely elucidated: do older persons sleep less simply because they need less sleep, or do they need more sleep than they can generate?

In a 2007 paper, Fragoso and Gill supported that “senescence in the form of usual aging is characterized by a reduction in health status, loss of physical function, and primary sleep disorders, all of which are capable of precipitating sleep complaints and adverse outcomes.” The authors consider sleep complaints as a consequence of multiple and interdependent predisposing (reduced sleep spindles, slow wave sleep, REM sleep, and advanced phase of sleep), precipitating (reduced health status, loss of physical functions, primary sleep disorders), and perpetuating factors (social isolation, loneliness, inactivity, inadequate sleep hygiene, caregiving, bereavement) (40).

Other authors have mainly supported the hypothesis that older persons’ sleep complaints are unrelated to the aging process “per se,” emphasizing the importance of comorbidities and primary sleep disorders (38; 02).

In an exhaustive review on sleep and human aging, it is possible to find all major studies in favor or against the two hypotheses (75). Some scientific evidence supports that sleep need is reduced in the elderly who show less intense "rebound” sleep, a minor reduction of attention after deprivation, and less subjective sleepiness with sleep restriction. Other authors argue that sleep need is not significantly changed while sleep-generating ability is impaired. Currently, no clear consensus exists, but the evidence seems to be slightly in favor of the hypothesis that older adults have an alteration in their ability to register, perceive, or generate the sleep they need (75).

Chronic conditions show a high prevalence in older adults. According to the National Sleep Foundation’s 2003 poll, 43% of involved persons reported two to three chronic conditions, 24% four or more, and only 10% reported none. The most prevalent conditions were hypertension (47%), arthritis (46%), enlarged prostate (22% of men), heart disease (18%), depression (16%), and diabetes (15%). Nocturia and related sleep disturbance were present in 65% of men and women. Other epidemiological studies and several papers confirmed these data. Each of these disturbances can cause sleep disorders.

On the other hand, a 2020 Swedish national ongoing population-based study with a 9-year follow-up demonstrated that moderate to severe sleep disturbances are associated with a higher speed of accumulating chronic disease, particularly musculoskeletal and neuropsychiatric disorders (103). The study emphasizes the importance of early detection and treatment of sleep disorders to possibly reduce chronic multimorbidity connected with aging.

Several sleep disturbances are highly prevalent in older adults and patients with dementia (02; 84; 49):

	• Insomnia
	• Sleep-disordered breathing (obstructive sleep apnea in particular)
	• Restless legs syndrome
	• Periodic limb movements
	• Rapid eye movement sleep parasomnias (REM sleep behavior disorder in particular)
	• Excessive daytime sleepiness

The Hypnolaus study on 3043 participants (age range: 40 to 85 years; 48% men) found a prevalence of moderate-severe obstructive sleep apnea in 23.4% of women and 49.7% of men: the prevalence increased from 60 years and over (54). REM sleep behavior disorder can precede a synucleinopathy by decades and has been introduced as a core criterion for diagnosing Lewy body dementia (77).

Hypertension, diabetes, and heart disease are often associated with sleep-disordered breathing, and depression is associated with insomnia. Hypertension, arthritis, depression, and diabetes mellitus are associated with sleep-related movement disorders such as restless legs syndrome. In the National Sleep Foundation’s 2003 poll, self-reported snoring, apnea, insomnia, and restless legs syndrome rose with the increase in the number of chronic conditions (111).

A retrospective, cross-sectional study on the clinical characteristics of sleep apnea in 102 geriatric inpatients confirmed that excessive daytime sleepiness and comorbidities burden were independently associated with a polygraphic obstructive sleep apnea diagnosis, emphasizing the importance of always suspecting obstructive sleep apnea in comorbid, sleepy older patients (81).

Medication use in the elderly is high, and a relevant contribution to the high number of medications used can be attributed to sleep disorders. In 2002, 44% of United States community-living older persons reported taking five or more medications a week, including herbal supplements, vitamins, and minerals (60).

In the National Sleep Foundation’s 2003 poll, 20% of participants used hypnotics at least a few nights a week. In the National Follow-Up Survey of Self-Care and Aging, 48.1% of persons used many medicines for arthritis, most often to improve sleep disruption related to pain (38).

A 2020 systematic review investigated the relationship between sleep complaints and frailty among older adults (115). Six cross‐sectional studies and one longitudinal study were considered and demonstrated consistent evidence of the association between subjective sleep quality and frailty. Data on insomnia symptoms, excessive daytime sleepiness, and sleep-wake patterns were inconclusive; the authors underlined that more studies with validated instruments are needed regarding these topics. On the other hand, insomnia and excessive daytime sleepiness predict 20-year mortality in older adult males as demonstrated by an Italian study conducted in the city of Udine on 750 subjects aged 65 years and older (78). Risk was determined to be independent of cancer, depression, dementia, cardiovascular diseases, and the use of sleeping pills. Moreover, excessive daytime sleepiness was associated with increased malnutrition, dysphagia, and vitamin D deficiency, regardless of age, gender, living status, polypharmacy, dementia, insomnia, and ischemic heart disease. The relationship seems to be bidirectional and emphasizes the benefit of assessing and treating excessive daytime sleepiness in malnutrition (62). Another study demonstrated that excessive daytime sleepiness was associated with increased falls and sarcopenia in a sample of 575 older adults (104).

In older adults, sleep seems to be more sensitive to circadian timing and circadian sleep-wake rhythm disorders. Persons with preclinical and clinical cognitive decline show relevant alterations in circadian sleep-wake rhythms, which are closely associated with amyloid deposition in the retina and, in particular, retinal melanopsin ganglion cells (64). Sleep disturbances are present in the early phases of dementia and can contribute to a faster and more severe cognitive decline.

A study by Bacalini and colleagues found an association between a specific genetic variant (rs3027178) in the circadian clock gene PER1 and susceptibility to Alzheimer disease and longevity in an Italian population (05). This study identified a significant association between the rs3027178 polymorphism in the PER1 circadian gene with Alzheimer disease, with the G allele being protective for Alzheimer disease. Interestingly, rs3027178 showed similar genotypic frequencies among patients with Alzheimer disease and centenarians. These findings suggest the involvement of the PER1 gene, specifically the rs3027178 polymorphism, in Alzheimer disease development and longevity in the Italian population, but the exact meaning of this association is not yet clear.

The prevalence of circadian sleep-wake rhythm disorders in older adults is not completely defined: they are difficult to identify only based on subjective complaints and behavioral aspects. For instance, early morning awakenings have been detected in 20% to 30% of older adults, but when excluding comorbidities such as depression, pain, physical limitations, and respiratory disturbances, only 4% of older adults report early morning awakenings, which are often difficult to differentiate from an advanced sleep phase disturbance in older adults and patients with dementia. The advanced sleep phase disturbance is rare among older persons, but it is more prevalent than in young adults and can be connected to sundowning, which is almost endemic in patients with dementia (114; 47). The delayed sleep-wake phase disorder is rare in older adults. Irregular sleep-wake rhythm disorder is more frequent in patients with dementia and among institutionalized individuals, partially due to the lack of environmental and behavioral inputs. Non-24-hour sleep-wake rhythm disorder is rare in older adults but may result from vision loss. Moreover, older shift workers use more hypnotics for severe sleep disturbances (119; 61). Circadian sleep-wake disorders seem connected to sundowning, which is almost endemic in patients with dementia but also present in nondemented older adults (18). More data on circadian dysfunction are needed in older persons and in patients with dementia using behavioral and biological markers to tailor specific therapies.

A 2021 cross-sectional and longitudinal study investigated the association between time spent in outdoor light and mood, sleep, and circadian rhythm-related outcomes (16). The researchers collected data from over 400,000 participants in the United Kingdom Biobank. The study revealed that greater exposure to outdoor light was associated with improved mood, better sleep quality, and healthier circadian rhythm-related outcomes. These results emphasize the role of outdoor light exposure for healthy aging (16).

Excessive daytime sleepiness, sleep deficiency, environmental problems, work and family demands interfering with sleep habits, and their global impact on older adults. In 2005, a population study considered a random sample of 16,583 men and women from central Pennsylvania between 20 to 100 years of age (12). The authors found that excessive daytime sleepiness, often linked to cognitive impairment and other sleep and medical disorders, declines between the ages of 30 and 75 years and at a greater rate after 75 years of age. However, it is present in the “young old” group of people, still employed, socially active, and driving vehicles, with evidently associated risks. Regarding this latter point, in a 2021 systematic review, Scarpelli and colleagues found that sleepiness has varying effects on driving abilities based on age, with older drivers being less affected by sleep loss than young adults (98). However, differences in lifestyle, such as the tendency of the elderly to avoid risky driving, led to some discrepancies in the findings.

In 2006, Wittman and colleagues introduced the circadian definition of social jet lag, a misalignment between circadian and social clocks (116): 69% of adults report at least 1 hour of social jet lag. It tends to decline with age, but together with shift work disorders, it may affect older persons (usually more vulnerable to misalignment of circadian rhythms) to a greater extent, acting on age-related sleep changes (97).

The National Sleep Foundation’s 2003 Sleep in America Poll on sleep and aging indicated that older adults aged 55 to 84 years were more regular in their sleep duration in weeknights and weekends (7 and 7.1 hours, respectively) as compared to persons aged 18 to 54 (84). According to this survey,13% of older persons sleep less than 6 hours during the week and 11% sleep less than 6 hours during weekends. Moreover, 9% of older adults sleep 9 hours and more during the weekend against 8% during the week.

A study conducted by Coelho and colleagues found that circadian misalignment, characterized by disruptions in the alignment between internal circadian rhythms and external environmental cues, was more present in subjects with COVID-19 infection and was associated with an increased risk of COVID-19 infection (21). These results suggest that maintaining proper circadian alignment may play a role in reducing the risk of COVID-19.

The overall impression is that since 2003, sleep habits have changed, and probably, analyzing also distinct age subgroups of older persons, sleep data could be different than before: this should be a new tool for the research agenda.

It is difficult to define specific social rhythms for older persons and women, particularly those whose working and familial rhythms are more interconnected. Moreover, the retirement age is changing, and many retired persons often maintain relevant intellectual, physical, and working activities until 75 years and older, also due to the opportunities given by our digital and interconnected world. To what extent the duration and timing of sleep is altered by work and retirement is not yet well known. Existing data report that people sleep longer and later after retirement, but available studies are mainly based on self-reported evaluations or comparisons between individuals. A study investigated 100 people aged between 61 and 72 years who were retired from paid work using accelerometers, diaries, and questionnaires (45). Measures were repeated after 1 and 2 years. Sleep duration increased by 21 minutes, whereas sleep efficiency remained substantially unchanged. Sleep onset and final awakening were delayed by 26 and 52 minutes, respectively, and midsleep was forwarded from 03:17 to 03:37 hours. Social jetlag decreased but still occurred after retirement.

A cross-sectional study on the association between social jet lag, metabolic syndrome, and type 2 diabetes in the general population found no significant association in older adults whereas it was found in younger adults with more than 1 hour of social jet lag. The authors described a reduced entity of social jet lag in adults above the age of 61 (24%) who had more metabolic syndrome at baseline, emphasizing the role of the longer previous exposition to social jet lag in older persons (63).

Usual sleep duration has substantially decreased since the 1960s, even among older persons who still drive and have a high prevalence of obstructive sleep apnea: these conditions are strongly associated with motor vehicle crashes in the general population (48).

Some mathematical models have been proposed to assess sleepiness, and these new methods may also be useful for older adults (01). A paper proposed new formulae to combine social jet lag and chrono-disruption concepts to compute sleep deficiency, defined as insufficient quality and quantity of sleep (32).

The clinical definition and detection of excessive daytime sleepiness is particularly challenging in the elderly with related problems in prevalence studies. Excessive daytime sleepiness is often related to medical and primary sleep disorders such as obstructive sleep apnea, circadian sleep-wake rhythm disorder, restless legs syndrome, and, in a minor percentage, central disorders of hypersomnolence. Excessive daytime sleepiness has been identified and confirmed as a risk factor for cognitive decline and dementia in older adults (43; 22). Moreover, excessive daytime sleepiness is an independent risk indicator for cardiovascular events and mortality in the elderly (30).

Drowsiness is most often established by self-reported napping behavior and, less often, by a scale (eg, the Epworth Sleepiness Scale). The latter is a brief self-administered questionnaire with scores ranging from 0 to 24, with higher scores denoting greater drowsiness. The Epworth Sleepiness Scale demonstrated reduced sensitivity and specificity in older persons and in cognitive decline (41); therefore, it should be used cautiously in these populations. Daytime napping can be a routine for many individuals at different stages of the life course and may have cultural influences. Napping may also be performed to compensate for nighttime sleep loss, to recover energy, and to reduce daytime sleepiness. In older adults, the progressive reduction of working and social activities offers more time for naps. Napping has been demonstrated to be more prevalent in older adults. The National Sleep Foundation’s 2003 poll reported one or more symptoms of insomnia in 46% of older adults aged 65 to 74 years and 50% among those aged 75 to 84 years, with rates for napping of 39% and 46%, respectively. These data are in accordance with the Established Populations for Epidemiologic Studies of the Elderly study (40). In a Japanese survey, 27.4% of older adults nap frequently (naps on 4 or more days per week) compared to only 14.4% of middle-aged adults. No data demonstrate that nap duration differs between older adults and other age groups (35; 42). According to Yoon and colleagues, older adults tend to nap more in the early evening, whereas younger adults nap in the afternoon (117), and this could contribute to the difficulty in identifying advanced sleep phase disturbances in older persons with cognitive decline. Napping is more frequent when associated with excessive daytime sleepiness, depression, pain, and nocturia but these are conditions often present in healthy aging (39; 65). A paper described the napping characteristics and cognitive performance in older adults, subdividing napping habits into six different age groups: 65 to 69, 70 to 74, 75 to 79, 80 to 84, 85 to 89, and over 90 years to better examine the phenomenon. In United States community-dwelling older adults, frequent, unintentional, and longer naps correlated with worse performance on cognitive tests or self-rated memory. Napping showed utility as a marker of higher risk for neurodegeneration for care and prevention programs (90).

New operational definitions and instruments to assess excessive daytime sleepiness in population studies, particularly in older persons, are necessary to separate social, physiological, and pathological aspects for the best therapeutic and preventive approaches. In 2012, Ohayon and colleagues described and used the Sleep-EVAL, a “knowledge-based expert system,” to detect excessive daytime sleepiness in a cohort of 15,929 persons from 15 American states, aged 18 to 102 years, with 16.9% retired persons. Excessive daytime sleepiness was more prevalent (27.8%) than previously reported. Individuals aged 55 to 64 and those over 65 years scored 22.9% and 24%, respectively, with significant differences only when compared to those aged 18 to 34. They underlined the importance of deeply and extensively investigating excessive daytime sleepiness using more descriptive dimensions, such as chronicity, severity, comorbidity, and age (87).

The need to distinguish excessive daytime sleepiness “per se,” secondary to primary sleep disorders (circadian sleep-wake rhythm disorder in particular) or related to social and environmental aspects, is crucial in clinical and therapeutic settings and, particularly, in neurodegenerative disorders. The association of biomarkers such as melatonin, cortisol, and body core temperature gives new opportunities (61) but more studies are needed.

Aging sleep and hormonal changes. Several hormonal changes have been considered to understand sleep changes in aging.

Growth hormone shows pulsatility during nocturnal sleep, regardless of the phase and fragmentation of sleep. An age-related decrease in growth hormone secretion has been demonstrated and in older adults its decreased secretion seems to parallel slow wave sleep decrease in an unclear manner. No clear evidence demonstrates that the secretion of prolactin alters sleep, but fragmented sleep in healthy older adults can decrease prolactin secretion. Sleep, particularly slow-wave sleep, inhibits cortisol secretion. Among older adults, changes in the circadian cortisol rhythm can be associated with altered circadian patterns and more frequent awakenings during the night.

Thyroid-stimulating hormone secretion follows a circadian pattern with a low level during the day and a peak connected to sleep. This circadian release does not show significant changes with aging, but some studies demonstrate that its total 24-hour secretion is decreased (07).

In aging, 24-hour melatonin secretion decreases but daytime melatonin may remain unaffected, whereas the nocturnal increase is significantly reduced when compared to young adults, and the complex associations with sleep are not completely understood. New evidence is expected in the coming years, also from older adults with cognitive decline (99; 65).

Sleep disturbances and biological sex differences: few available data on gender aspects. In 2014, a report from the Society for Women’s Health Research (72) highlighted the importance of considering the role of sex (and gender) differences in sleep and its disturbances at any age. As they age, women report a subjective worsening of sleep parameters (ie, sleep quality, sleep latency, total sleep time, sleep efficiency) as compared to men (110; 71). However, using objective measures of sleep (ie, actigraphy and polysomnography), older men show shorter and more fragmented sleep with lower slow wave sleep and REM and increased lighter sleep stages as compared to women (109; 110). This discrepancy between self-reported and objective sleep could be partially explained by the evidence that the circadian period, which regulates melatonin production and temperature rhythms, is significantly shorter in women than in men (29; 06). Even if sleep timing appears to be equivalent in the two sexes, women’s circadian times are set earlier than men, leading to a greater predisposition for women to advanced sleep-wake phase disorder and insomnia (119; 46; 61). An advanced circadian phase may be connected to early morning awakening, a common complaint in menopausal women (92).

Perimenopausal, menopausal, and postmenopausal women complain of worse insomnia symptoms, have a higher risk of developing obstructive sleep apnea, and report an increase in restless legs syndrome and sleep-disordered breathing severity (34; 80). Altered estrogen and progesterone levels may negatively impact the upper airway function with a higher incidence of sleep-disordered breathing in post-menopause (69). Sleep duration correlates with obesity in children and young adults: data on older persons are less clear, but three wide studies in the United States, Finland, and Spain demonstrated a stronger association in older women. Short sleep duration has been demonstrated to be associated with an increased risk of hypertension, coronary heart disease, and stroke, with women showing higher vulnerability. Other studies found that longer sleep duration correlated with diabetes and cardiovascular disease risk and mortality, probably through comorbidities. Objective measurements of sleep parameters demonstrated that the interaction of sleep duration and insomnia or poor sleep quality had a higher impact on cardiovascular disease risk without significant differences between men and women. However, studies with objective sleep measurements in older persons are limited at this time, and more prospective studies are needed (19; 107). Obesity is clearly linked to sleep-disordered breathing, and in a wide polysomnographic study, sleep-disordered breathing severity determined a higher risk of cardiovascular disease and related mortality in older women than men (93). Even considering all this evidence, a bias in the access to sleep clinics still exists. For example, the prevalence of referrals to a sleep clinic for obstructive sleep apnea is twice to three times higher in men than in women (09; 04). Compared to men with similar obstructive sleep apnea severity, women diagnosed with obstructive sleep apnea are usually older, have higher BMI, present with more comorbidities (100; 09; 04), and have a higher risk of frailty (31; 82). Moreover, they report a poorer quality of life associated with obstructive sleep apnea, exacerbated by comorbid insomnia, which is usually why women are more often referred to sleep clinics (100; 108). This suggests an under-recognition of obstructive sleep apnea in women explained by a different obstructive sleep apnea symptoms’ presentation. Although men usually report more snoring, daytime sleepiness, and witnessed apnea, women complain more about fatigue, insomnia, restless legs, depression, morning headaches, and impaired cognition (09; 85; 14).

There is a dearth of information regarding sleep patterns and disturbances in relation to gender as an expression of social, cultural, and economic determinants as well as in relation to different gender identities. In past decades, the literature documented associations between social inequalities and several cardiovascular and chronic diseases and sleep disorders. Inequities regarding sleep health seem to contribute to disparities in health outcomes with sex and, possibly, gender specifics. Several social determinants of health among middle-aged and older adults affect sleep duration, sleep satisfaction, and sleep continuity or efficiency. Relevant associations in at least one domain of sleep health were observed by age, sex, education, marital status, employment, race and ethnicity, and sexual orientation in over 30,097 community-dwelling adults aged 45 to 85 years in Canada. Sleep dissatisfaction, insomnia symptoms, and daytime impairment were consistently associated with a higher prevalence of dissatisfaction with life, psychological distress, and poor self-reported mental health, particularly in men, contrary to evidence for other health outcomes, which generally show stronger effects in women although associations were still statistically significant in both sexes (96). Apparently, conflicting data on these topics need to be better elucidated. Regarding different gender identities, a narrative review has highlighted worse sleep health in sexual and gender minority people compared with their cisgender and heterosexual peers (27). However, a 2022 study comparing cognitive performance and structural brain parameters of older adults in same-sex relationships, and mixed-sex relationships found less impairment in the cognitive profile of sex relationship participants compared to mixed-sex relationship participants (73). Therefore, more research is needed on sleep and aging, taking into account not only biological sex differences but also lifestyle, social and cultural determinants, and gender identities.

Prognosis and complications

Untreated sleep disturbances can determine more medication use and contribute to the onset of other chronic conditions. Sleep supports and drives major physiological functions such as immune, metabolic, endocrine, thermoregulatory, and cardiovascular functions (56). Moreover, sleep is involved in motor control, learning and memory, attention, motivation, emotional balance, and decision-making. Age-related sleep disturbances can impair all these functions. Sleep disorders since middle age can contribute to the pathological preclinical processes of several neurodegenerative disorders, especially Alzheimer disease (75; 70), and they are an independent risk factor for cognitive decline. Sleep and sleep-wake rhythm disturbances need to be managed at an early stage, considering the importance of the timing of risk factors for dementia (79).

Clinical vignette

Fictitious clinical case. A 54-year-old man was referred to a sleep center because of excessive daytime sleepiness (often arising abruptly and exacerbating in the afternoon) and fatigue he had experienced for almost 5 years. Due to work-related demands as a farmer, he often slept 3 to 4 hours per night and sustained strenuous physical activity. His wife reported snoring and cessation of breathing during the night. Moreover, she noted sleep-talking and dream-enactment behaviors; however, neither she nor the patient were injured due to these episodes. The patient remembered unpleasant dreams with fearful animals (such as snakes) since teenage-hood. He did not report cataplexy, sleep paralysis, or hypnagogic hallucinations. His daytime sleepiness was assessed with the Epworth Sleepiness Scale, which scored 16 out of 24, indicative of severe excessive daytime sleepiness. BMI was normal; the general and neurologic examinations were in the normal range.

The patient underwent a laboratory full night video-polysomnography, which demonstrated the absence of sleep-disordered breathing (Respiratory Disturbance Index less than five events per hour, no significant oxygen desaturations) and documented difficulty falling asleep, total sleep time of 370 minutes, poor sleep efficiency (80%), reduced presence of slow wave sleep, and continuous snoring without related arousals. Neither REM without atonia nor parasomnias were detected. During the consecutive 3 days of observation in the sleep center, sleeping almost 6 hours per night, the patient did not show clinically detectable diurnal hypersomnolence, as confirmed by the normal values obtained at the Multiple Sleep Latency Test performed after the video polysomnography.

According to the clinical and sleep studies results, the patient was diagnosed with “insufficient sleep syndrome associated with snoring.”

Despite the attempts to improve his sleep hygiene, sporadic use of hypnotics, and a temporary remission of his symptoms, after 2 years the patient developed more hypersomnolence, but he did not undergo new clinical controls until 15 years later. In the meantime, he experienced two near-miss car crashes with his tractor.

At the second sleep evaluation, at the age of 69, the patient reported longer nighttime sleep in the last 2 years as compared to the period of the first sleep studies: around 5 hours per night in spring/summer and 7 or 8 hours per night in autumn and winter, but he experienced sleep attacks under any circumstances. He usually woke up once or twice at night due to urinary necessity and breathing events. He usually took naps of about 15 minutes, two or three times per week, judging them unrefreshing. His wife reported episodes of possible dream-enactment behaviors. The BMI was still normal. Since the age of 67, the patient was under antihypertensive treatment with a diuretic in the morning.

The patient underwent a first full-night video polysomnography, which demonstrated a total sleep time of 390 minutes and poor sleep efficiency (76.5%). REM sleep latency was normal, REM sleep percentage was reduced (15%), and REM sleep without atonia was absent. RDI was 15.6 events per hour, associated with an oxygen desaturation index of 15.1 events per hour, and T90 was less than 30%. Neither REM nor non-REM parasomnias events were detected. No pulmonary disease was diagnosed.

Consistent with the finding of moderate obstructive sleep apnea syndrome, the patient underwent a second video polysomnography the following night for continuous positive airway pressure titration, which resulted in good control of the apneic events, persistently reduced sleep efficiency (75.2%), and a total sleep time of 6 hours. REM sleep latency was still normal, and its presence was slightly reduced.

The patient underwent a Multiple Sleep Latency Test after the night of continuous positive airway pressure titration; the test documented pathological values indicative of excessive daytime sleepiness (mean sleep latency of 5.4 minutes) without anticipations of REM sleep. The Multiple Sleep Latency Test was followed by a 24-hour polygraphic Holter EEG comprehending a night with continuous positive airway pressure utilization, which demonstrated a total 24-hour sleep of 7 hours, without daytime naps, no anticipations of REM sleep, and persistent poor sleep efficiency (76.4%).

The final diagnosis was moderate obstructive sleep apnea syndrome and maintaining insomnia with recurrent periods of sleep deprivation due to work-related demands. The patient did not accept the use of hypnotics but only the use of vegetal integrators at bedtime.

After initial difficulties in using continuous positive airway pressure, the patient used the device almost 5 hours per night, 90% of the nights for 3 months with good control of the diurnal hypersomnolence. Neither car accidents nor near-miss car crashes were reported. The wife did not report abnormal behaviors during sleep.

The patient is under regular annual ambulatory controls with periodic actigraphic monitoring of his sleep-wake profile as well as cognitive assessment to investigate any changes.

Biological basis

Sleep impairments during aging are connected to neurophysiological and neurochemical changes in the brainstem ascending arousal system, thalamus, hypothalamus, and other cortical brain regions. Altered light inputs to melanopsin retinal cells are pivotal in the age-related dysregulation of circadian sleep-wake rhythm. Several mechanisms are interdependent, whereas others are not, and this explains the high interindividual variability in sleep alterations among older adults of the same age. Primary sleep disorders and other factors such as medication use, nocturia, chronic pain, hormonal changes, psychiatric conditions, and medical comorbidities can contribute to sleep disturbances among the elderly.

Etiology and pathogenesis

Inflammation is pivotal in cellular senescence, and proinflammatory cellular phenotypes are associated with several age-related diseases and dementia risk. A study of 29 individuals aged 61 to 84 years demonstrated that a partial night sleep deprivation induced a change in leukocytes towards the expression of genes connected to senescence, DNA response to damage, and p16, a protein that can inhibit cell cycle progression. Other leukocyte studies confirmed the hypothesis that sleep disturbances and insomnia are linked to inflammation and cellular senescence, all processes involved in aging and cognitive decline. Sleep disturbances can stimulate stress responses such as noradrenergic activity that can act on the immune system and upregulate inflammatory systemic responses. In the sleep-wake transition, the central noradrenergic tone increases while glymphatic clearance decreases with less glymphatic clearance of neurotoxic proteins. Moreover, proinflammatory microglial activation can increase the risk of nonhealthy aging and Alzheimer disease (57).

On the other hand, several sleep disturbances (insomnia, restless legs syndrome, sleep-disordered breathing, excessive daytime sleepiness) and sleep structure changes occur in inflammatory and immunologic diseases with possible mutual enhancement (20).

Obstructive sleep apnea is highly connected to a proinflammatory state that can contribute to cognitive decline. In patients with obstructive sleep apnea, several circulating biomarkers connected to Alzheimer disease and vascular dementia (beta-amyloid and tau proteins, inflammatory cytokines, antioxidants and oxidized products, homocysteine, and clusterin) are altered. Several obstructive sleep apnea and dementia biomarkers alterations can be reversed by continuous positive airway pressure treatment. New evidence suggests that treating obstructive sleep apnea, starting in midlife, is important to prevent cognitive decline (25; 08; 03; 66). Results from Memories, one prospective clinical trial on the use of continuous positive airway pressure in older adults with mild cognitive impairment and obstructive sleep apnea, demonstrated that correct treatment adherence significantly improved cognitive function at 1-year follow-up (94).

Moreover, neurodegenerative processes such as beta-amyloid deposition and neurofibrillary tangles are associated with sleep disturbances in a bidirectional manner (52; 75). Since the earliest or preclinical phases of Alzheimer disease and other forms of dementia, subjective and objective measures of poor sleep correlate with a beta-amyloid burden as well as cerebrospinal fluid levels of beta-amyloid and phosphorylated tau (105; 67; 74; 106).

The misalignment between the desired timing of wakefulness and sleep and the ability to fall asleep and maintain sleep is the core of circadian sleep-wake rhythm disorders.

This mismatch can derive from biological or behavioral factors. Circadian sleep-wake rhythm disorders determine altered rest-activity patterns, resulting in more frequent naps during daytime and a minor consolidation of sleep at night, increased irritability, and depressive symptoms. Their prevalence is estimated in up to 10% of adult patients. The phase (timing) of the circadian rhythms of melatonin, temperature, and cortisol has been demonstrated to move earlier (advance) in older persons, and the amplitude of these rhythms is reduced. Older adults, including patients with Alzheimer disease and other dementias, may share reduced neuronal activity in the biological clock centers associated with reduced light reaching the back of the eye modified by physiological age-related ocular changes. Amyloid depositions have been found in the retina of patients with Alzheimer disease, particularly in melanopsin cells, in early stages of the disease, supporting the hypothesis of an early circadian dysfunction in Alzheimer disease (64; 36).

Epidemiology

Sleep as a risk factor for dementia. In studying the incidence and prevalence of dementia (Alzheimer disease in particular), there are several methodological problems linked to the complex etiology, the uncertain onset, and the complex definition of the preclinical phases. Moreover, particular attention is necessary regarding sex and gender differences and the timing effect of risk factors with age as a driver (95; 79).

A study on the relationship between the age of onset of insomnia (before or after 65 years) and sex on cognition and depressive symptoms demonstrated that the onset of insomnia later in life, insomnia symptoms, excessive daytime sleepiness, and depression were risk factors for cognitive decline in females (58). In men, the risk was represented only by excessive daytime sleepiness and depression. An Italian multicenter study on sleep and circadian dysfunction as markers of mild cognitive impairment and Alzheimer disease revealed some sex differences (50). A confusion-matrices algorithm demonstrated that actigraphic sleep and circadian data had good predictive power (89.87%) in forecasting the disease status (healthy volunteers, mild cognitive impairment, or mild to moderate Alzheimer disease). Sleep regularity was lower in patients with Alzheimer disease compared to controls as well as in males with Alzheimer disease compared to male controls, males with mild cognitive impairment, and females with Alzheimer disease. Mesor was significantly lower in males in the overall population. After adjusting for age, a reduced circadian amplitude was detected in men in the overall population and in subjects with Alzheimer disease but not in mild cognitive impairment. Differences in actigraphic data along aging and dementia trajectories in men and women are intriguing and need further elucidation and investigation.

Several longitudinal studies have shown that different sleep disturbances (insomnia, sleep inadequacy, poor sleep, change in sleep duration/quality, or daytime sleepiness) are associated with an increased risk for dementia and Alzheimer disease (89; 53; 10; 101; 22). These data demonstrate that both midlife and late-life sleep characteristics are important risk factors for dementia, emphasizing the need to investigate sleep during different stages of the life course. Insomnia in midlife and long sleep duration or insomnia later in life have demonstrated a higher risk for dementia later in life (102), supporting the “timing hypothesis” of risk factors.

In older adults, both short sleep duration (less than 6 hours per night) and long sleep duration (more than 8 hours per night) are associated with an increased risk for dementia. In some studies, only long sleep duration in midlife (8 hours or more) (113) or late life (9 hours or more) (11) was associated with a higher risk for dementia and Alzheimer disease. These different results are not clearly elucidated and may be due to different follow-up periods and confounders adjusted for. Other limitations may be related to short follow-up periods, small sample sizes, and methodology used for dementia diagnosis. Moreover, some studies were conducted only on male cohorts, whereas others only on female or mixed cohorts. Anyway, considering the extensive current epidemiological data, a meta-analysis demonstrated that persons reporting sleep disturbances have a higher risk of incident all-cause dementia, Alzheimer disease, and vascular dementia. Moreover, a subgroup analysis showed that insomnia increased Alzheimer disease but not vascular or all-cause dementia risk. Sleep-disordered breathing was demonstrated to be associated with an increased risk of all-cause dementia, Alzheimer disease, and vascular dementia (101); the risk is for neuropathology and clinical syndrome (03; 66).

Management

Managing social jet lag, sleep debt, and sleep disturbances since young and middle age may be important in preventing chronic conditions and cognitive decline in older persons. Interventions may include improvements in behavioral routines and sleep hygiene, physical exercise, stress management, and regulation of the exposure levels to natural light (55).

In older adults, primary sleep disorders should be managed according to evidence-based recommendations but with particular attention to some specific age-related aspects. Recommendations for managing sleep disturbances in older adults can be used, at least partly, even for persons with cognitive decline. These recommendations should be periodically updated: there are few double-blind, randomized controlled trials concerning pharmacological and nonpharmacological treatments (13; 51; 118). For instance, cognitive behavioral therapy for insomnia is recommended as the first-line treatment of chronic insomnia (83), but few trials have specifically involved menopausal women and older adults.

Light therapy deserves a special mention, especially for older adults with cognitive decline and Alzheimer disease. Several studies demonstrated that timed exposure to short-wavelength light can ameliorate nighttime sleep efficiency, daytime wakefulness, and evening agitation. Large randomized controlled trials with more targeted light intensities and compliance-enhancing devices are needed (36).

Continuous positive airway pressure treatment of obstructive sleep apnea is recommended among older adults. It can reduce sleepiness, fatigue, and depressive symptoms, contributing to a better quality of life. In patients with dementia, continuous positive airway pressure improves sleep and agitation, can contribute to reducing cardio and cerebrovascular comorbidities, and possibly can reduce the progression of cognitive decline. In older persons with dementia, compliance to continuous positive airway pressure often requires a valid caregiver, but it is acceptable and does not significantly hinder the therapy (23; 24; 91; 81).

References

01: Akerstedt T. Using mathematical models to predict sleepiness. In: Garbarino S, Nobili L, Costa G., editors. Sleepiness and Human Impact Assessment. Milano: Springer, 2014:63-9.
02: Ancoli-Israel S. Sleep and its disorders in aging populations. Sleep Med 2009;10 Suppl 1:S7-11. PMID 19647483
03: Andre C, Rehel S, Kuhn E, et al. Association of sleep-disordered breathing with Alzheimer disease biomarkers in community-dwelling older adults: a secondary analysis of a randomized clinical trial. JAMA Neurol 2020;77(6):716-24. PMID 32202593
04: Appleton SL, Gill TK, Lang CJ, et al. Prevalence and comorbidity of sleep conditions in Australian adults: 2016 Sleep Health Foundation national survey. Sleep Health 2018;4(1):13-9. PMID 29332673
05: Bacalini MG, Palombo F, Garagnani P, et al. Association of rs3027178 polymorphism in the circadian clock gene PER1 with susceptibility to Alzheimer's disease and longevity in an Italian population. Geroscience 2022;44(2):881-96. PMID 34921659
06: Bailey M, Silver R. Sex differences in circadian timing systems: implications for disease. Front Neuroendocrinol 2014;35(1):111-39. PMID 24287074
07: Balbo M, Leproult R, Van Cauter E. Impact of sleep and its disturbances on hypothalamo-pituitary-adrenal axis activity. Int J Endocrinol 2010; 2010:759234. PMID 20628523
08: Baril AA, Carrier J, Lafrenière A, et al. Biomarkers of dementia in obstructive sleep apnea. Sleep Med Rev 2018;42:139-48. PMID 30241998
09: Basoglu OK, Tasbakan MS. Gender differences in clinical and polysomnographic features of obstructive sleep apnea: a clinical study of 2827 patients. Sleep Breath 2017; 22(1):241-9. PMID 28197893
10: Benedict C, Byberg L, Cedernaes J, et al. Self-reported sleep disturbance is associated with Alzheimer's disease risk in men. Alzheimers Dement 2015;11(9):1090-7. PMID 25438949
11: Benito-Leon J, Bermejo-Pareja F, Vega S, Louis ED. Total daily sleep duration and the risk of dementia: a prospective population-based study. Eur J Neurol 2009;16(9):990-7. PMID 19473367
12: Bixler EO, Vgontzas AN, Lin HM, Calhoun SL, Vela-Bueno A, Kales A. Excessive daytime sleepiness in a general population sample: the role of sleep apnea, age, obesity, diabetes, and depression. J Clin Endocrinol Metab 2005;90(8):4510-5. PMID 15941867
13: Bloom HG, Ahmed I, Alessi CA, et al. Evidence-based recommendations for the assessment and management of sleep disorders in older persons. J Am Geriatr Soc 2009;57(5):761-89. PMID 19484833
14: Bonsignore MR, Saaresranta T, Riha RL. Sex differences in obstructive sleep apnoea. Eur Respir Rev 2019;28(154):190030. PMID 31694839
15: Brayet P, Petit D, Frauscher B, et al. Quantitative EEG of rapid-eye-movement sleep: a marker of amnestic mild cognitive impairment. EEG Clin Neurosci 2015;47(2):134-41. PMID 26323578
16: Burns AC, Saxena R, Vetter C, et al. Time spent in outdoor light is associated with mood, sleep, and circadian rhythm-related outcomes: a cross-sectional and longitudinal study in over 400,000 UK Biobank participants. J Affect Disord 2021;295:347-52. PMID 34488088
17: Campbell SS, Murphy PJ. The nature of spontaneous sleep across adulthood. J Sleep Res 2007;16(1):24-32. PMID 17309760
18: Canevelli M, Valletta M, Trebbastoni A, et al. Sundowning in dementia: clinical relevance, pathophysiological determinants, and therapeutic approaches. Front Med (Lausanne) 2016;3:73. PMID 28083535
19: Carrier J, Semba K, Deurveilher S, et al. Sex differences in age-related changes in the sleep-wake cycle. Front Neuroendocrinol 2017;47:66-85. PMID 28757114
20: Clark IA, Vissel B. Inflammation-sleep interface in brain disease: TNF, insulin, orexin. J Neuroinflammation 2014;11:1-11. PMID 24655719
21: Coelho J, Micoulaud-Franchi JA, Wiet AS, Nguyen D, Taillard J, Philip P. Circadian misalignment is associated with Covid-19 infection. Sleep Med 2022;93:71-4. PMID 35447468
22: Cohen AD, Jia Y, Smagula S, et al. Cognitive functions predict trajectories of sleepiness over 10 years: a population-based study. J Gerontol A Biol Sci Med Sci 2021;76(3):520-7. PMID 32405646
23: Cooke JR, Ancoli-Israel S, Liu L, et al. Continuous positive airway pressure deepens sleep in patients with Alzheimer’s disease and obstructive sleep apnea. Sleep Med 2009a;10(10):1101-6. PMID 19699148
24: Cooke JR, Ayalon L, Palmer BW, et al. Sustained use of CPAP slows deterioration of cognition, sleep, and mood in patients with Alzheimer’s disease and obstructive sleep apnea: a preliminary study. J Clin Sleep Med 2009b;5(4):305-9. PMID 19968005
25: Cordella A, Romigi A, Izzi F, et al. Obstructive sleep apnea is associated with early but possibly modifiable Alzheimer’s disease biomarkers changes. Sleep 2017;42:1-10. PMID 28329084
26: Coutrot A, Lazar AS, Richards M, et al. Reported sleep duration reveals segmentation of the adult life-course into three phases. Nat Commun 2022;13 (1);7697. PMID 36509747
27: Dolsen EA, Byers AL, Flentje A, et al. Sleep disturbance and suicide risk among sexual and gender minority people. Neurobiol Stress 2022;21:100488. PMID 36164391
28: Dorffner G, Vitr M, Anderer P. The effects of aging on sleep architecture in healthy subjects. Adv Exp Med Biol 2015;822:93-100. PMID 25416113
29: Duffy JF, Cain SW, Chang AM, et al. Sex difference in the near-24-hour intrinsic period of the human circadian timing system. Proc Natl Acad Sci U S A 2011;108 Suppl 3:15602-8. PMID 21536890
30: Empana JP, Dauvilliers Y, Dartigues JF, et al. Excessive daytime sleepiness is an independent risk indicator for cardiovascular mortality in community-dwelling elderly the three city study. Stroke 2009;1219-25. PMID 19246707
31: Endeshaw YW, Unruh ML, Kutner M, Newman AB, Bliwise DL. Sleep-disordered breathing and frailty in the Cardiovascular Health Study Cohort. Am J Epidemiol 2009;170(2):193-202. PMID 19465743
32: Erren TC, Grob JV, Lewis P. Computing sleep deficiency. J Sleep Res 2018;27(3):e12630. PMID 29159867
33: Espiritu JR. Aging-related sleep changes. Clin Geriatr Med 2008;24(1):1-14. PMID 18035227
34: Fabbrini M, Arica I, Tramonti F, et al. Sleep disorders in menopause: results from an Italian Multicentric Study. Arch Ital Biol 2015;153(2-3):204-13. PMID 26742674
35: Ficca G, Axelsson J, Mollicone DJ, Muto V, Vitiello M V. Naps, cognition and performance. Sleep Med Rev 2010;14(4):249-58. PMID 19962331
36: Figueiro MG. Light, sleep and circadian rhythms in older adults with Alzheimer’s disease and related dementias. Neurodegener Dis Manag 2017;7(2):119-45. PMID 28534696
37: Floyd JA, Janisse JJ, Jenuwine ES, Ager JW. Changes in REM-sleep percentage over the adult lifespan. Sleep 2007;30(7):829-36. PMID 17682652
38: Foley D, Ancoli-Israel S, Britz P, Walsh J. Sleep disturbances and chronic disease in older adults: results of the 2003 National Sleep Foundation Sleep in America Survey. J Psychosom Res 2004;56(5):497-502. PMID 15172205
39: Foley DJ, Vitiello M V, Bliwise DL, Ancoli-Israel S, Monjan AA, Walsh JK. Frequent napping is associated with excessive daytime sleepiness, depression, pain, and nocturia in older adults: findings from the National Sleep Foundation 2003 Sleep In America poll. Am J Geriatr Psychiatry 2007;15(4):344-50. PMID 17384317
40: Fragoso CA, Gill TM. Sleep complaints in community-living older persons: a multifactorial geriatric syndrome. J Am Geriatr Soc 2007;55(11):1853-66. PMID 17916123
41: Frohnhofen H, Popp R, Willmann V, Heuer HC, Firat A. Feasibility of the Epworth Sleepiness Scale in a sample of geriatric in-hospital patients. J Physiol Pharmacol 2009;60 Suppl 5:45-9. PMID 20134038
42: Furihata R, Kaneita Y, Jike M, Ohida T, Uchiyama M. Napping and associated factors: a Japanese nationwide general population survey. Sleep Med 2016;20(2016):72-9. PMID 27318229
43: Gabelle A, Gutierrez L, Jaussent I, et al. Excessive sleepiness and longer nighttime in bed increase the risk of cognitive decline in frail elderly subjects: The MAPT-Sleep Study. Front Aging Neurosci 2017;9:312. PMID 29033827
44: Garbarino S, Nobili L, Costa G. Sleepiness and Human Impact Assessment. Springer Milan, 2014.
45: Garefelt J, Gershagen S, Kecklund G, Westerlund H, Platts LG. How does cessation of work affect sleep? Prospective analyses of sleep duration, timing and efficiency from the Swedish Retirement Study. J Sleep Res 2021;30(3):e13157. PMID 32815209
46: Gervais NJ, Mong JA, Lacreuse A. Ovarian hormones, sleep and cognition across the adult female lifespan: an integrated perspective. Front Neuroendocrinol 2017;47:134-53. PMID 28803147
47: Gnanasekaran G. “Sundowning” as a biological phenomenon: current understandings and future directions: an update. Aging Clin Exp Res 2016;28(3):383-92. PMID 26243434
48: Gottlieb DJ, Ellenbogen JM, Bianchi MT, Czeisler CA. Sleep deficiency and motor vehicle crash risk in the general population: a prospective cohort study. BMC Med 2018;16(44):1-10. PMID 29554902
49: Guarnieri B, Adorni F, Musicco M, et al. Prevalence of sleep disturbances in mild cognitive impairment and dementing disorders: a multicenter Italian clinical cross-sectional study on 431 patients. Dement Geriatr Cogn Disord 2012;33(1):50-8. PMID 22415141
50: Guarnieri B, Maestri M, Cucchiara F, et al. Multicenter study on sleep and circadian alterations as objective markers of mild cognitive impairment and Alzheimer's disease reveals sex differences. J Alzheimers Dis 2020;78(4):1707-19. PMID 33185597
51: Guarnieri B, Musicco M, Caffarra P, et al. Recommendations of the Sleep Study Group of the Italian Dementia Research Association (SINDem) on clinical assessment and management of sleep disorders in individuals with mild cognitive impairment and dementia: a clinical review. Neurol Sci 2014;35(9):1329-48. PMID 25037740
52: Guarnieri B, Sorbi S. Sleep and cognitive decline: a strong bidirectional relationship. It is time for specific recommendations on routine assessment and the management of sleep disorders in patients with mild cognitive impairment and dementia. Eur Neurol 2015;74(Mci):43-8. PMID 26159605
53: Hahn EA, Wang HX, Andel R, Fratiglioni L. A change in sleep pattern may predict Alzheimer disease. Am J Geriatr Psychiatry 2014;22(11):1262-71. PMID 23954041
54: Heinzer R, Vat S, Marques-Vidal P, et al. Prevalence of sleep-disordered breathing in the general population: The HypnoLaus study. Lancet Respir Med 2015;3(4):310-8. PMID 25682233
55: Irish LA, Kline CE, Gunn HE, Buysse DJ, Hall MH. The role of sleep hygiene in promoting public health: a review of empirical evidence. Sleep MedRev 2015;22:23-36. PMID 25454674
56: Irwin MR. Why sleep is important for health: a psychoneuroimmunology perspective. Annu Rev Psychol 2015;3(66):143-72. PMID 25061767
57: Irwin MR, Vitiello M V. Implications of sleep disturbance and inflammation for Alzheimer’s disease dementia. Lancet Neurol 2019;18(3):296-306. PMID 30661858
58: Ji X, Fu Y. The role of sleep disturbances in cognitive function and depressive symptoms among community-dwelling elderly with sleep complaints. Int J Geriatr Psychiatry 2021;36(1):96-105. PMID 33411399
59: Ju Y, Lucey BP, Holtzman DM. Sleep and Alzheimer disease pathology--a bidirectional relationship. Nat Rev Neurol 2014;10(2):115-9. PMID 24366271
60: Kaufman DW, Kelly JP, Rosenberg L, et al. Recent patterns of medication use in the ambulatory adult population of the United States. JAMA 2003;287(3):337. PMID 11790213
61: Kim JH, Duffy JF. Circadian rhythm sleep-wake disorders in older adults. Sleep Med Clin 2017;13(1):39-50. PMID 29412982
62: Koc Okudur S, Soysal P. Excessive daytime sleepiness is associated with malnutrition, dysphagia, and vitamin D deficiency in older adults. J Am Med Dir Assoc 2021;22(10):2134-9. PMID 34181909
63: Koopman AD, Rauh SP, van Riet E, et al. The association between social jetlag, the metabolic syndrome, and type 2 diabetes mellitus in the general population: The New Hoorn Study. J Biol Rhythms 2017;32(4):359-68. PMID 28631524
64: La Morgia C, Ross-cisneros FN, Koronyo Y, et al. Melanopsin retinal ganglion cell loss in Alzheimer disease. Ann Neurol 2015;79:90-109. PMID 26505992
65: Li J, Vitiello M V, Gooneratne NS. Sleep in normal aging. Clin Sleep Med 2017;13(1):1-11. PMID 29412976
66: Liguori C, Maestri M, Spanetta M, et al. Sleep-disordered breathing and the risk of Alzheimer's disease. Sleep Med Rev 2021;55:101375. PMID 33022476
67: Liguori C, Romigi A, Nuccetelli M, et al. Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease. JAMA Neurol 2014;71(12):1498-505. PMID 25322206
68: Liguori C, Mercuri NB, Izzi F, et al. Obstructive sleep apnea is associated with early but possibly modifiable Alzheimer’s disease biomarkers changes. Sleep 2017;40(5). PMID 28329084
69: Lin CM, Davidson TM, Ancoli-Israel S. Gender differences in OSA and treatment implications. Sleep Med Rev 2008;12(6):481-96. PMID 18951050
70: Lucey BP, McCullough A, Landsness EC, et al. Reduced non-rapid eye movement sleep is associated with tau pathology in early Alzheimer's disease. Sci Transl Med 2019;11(474):eaau6550. PMID 30626715
71: Madrid-Valero JJ, Martínez-Selva JM, Ribeiro do Couto B, Sánchez-Romera JF, Ordoñana JR. Age and gender effects on the prevalence of poor sleep quality in the adult population. Gac Sanit 2017;31(1):18-22. PMID 27474487
72: Mallampalli MP, Carter CL. Exploring sex and gender differences in sleep health: a Society for Women's Health Research Report. J Womens Health (Larchmt) 2014;23(7):553-62. PMID 24956068
73: Manca R, Correro AN, Gauthreaux K, Flatt JD. Divergent patterns of cognitive deficits and structural brain alterations between older adults in mixed-sex and same-sex relationships. Front Hum Neurosci 2022;16:909868. PMID 36118969
74: Mander BA, Marks SM, Vogel JW, et al. Beta-amyloid disrupts human NREM slow waves and related hippocampus-dependent memory consolidation. Nat Neurosci 2015;18(7):1051-7. PMID 26030850
75: Mander BA, Winer JR, Walker MP. Sleep and Human Aging. Neuron 2017;94(1):19-36. PMID 28384471
76: McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 2011;7(3):263-9. PMID 21514250
77: McKeith IG, Boeve BF, Dickson DW, et al. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology 2017;89(1):88-100. PMID 28592453
78: Merlino G, Lorenzut S, Gigli GL, et al. Insomnia and daytime sleepiness predict 20-year mortality in older male adults: data from a population-based study. Sleep Med 2020;73:202-7. PMID 32858331
79: Mielke MM, Vemuri P, Rocca WA. Clinical epidemiology of Alzheimer’s disease: assessing sex and gender differences. Clin Epidemiol 2014;6:37-48. PMID 24470773
80: Mirer AG, Young T, Palta M, Benca RM, Rasmuson A, Peppard PE. Sleep-disordered breathing and the menopausal transition among participants in the Sleep in Midlife Women Study. Menopause 2017;24(2):157-62. PMID 27760083
81: Monti A, Doulazmi M, Nguyen-Michel VH, Pautas E, Mariani J, Kinugawa K. Clinical characteristics of sleep apnea in middle-old and oldest-old inpatients: symptoms and comorbidities. Sleep Med 2021;82:179-85. PMID 33951603
82: Moreno-Tamayo K, Manrique-Espinoza B, Guerrero-Zúñiga S, Ramírez-García E, Sánchez-García S. Sex differences in the association between risk of obstructive sleep apnea, insomnia, and frailty in older adults. Nat Sci Sleep 2021;13:1461-72. PMID 34456596
83: Morgenthaler T, Kramer M, Alessi C, et al. Practice parameters for the psychological and behavioral treatment of insomnia: an update: an American Academy of Sleep Medicine report. Sleep 2006;29:1415-9. PMID 17162987
84: National Sleep Foundation. 2003 Sleep in America poll. Accessed January 2020. Available at: http://www.sleepfoundation.org. National Sleep Foundation, 2003.
85: Nigro CA, Dibur E, Borsini E, et al. The influence of gender on symptoms associated with obstructive sleep apnea. Sleep Breath 2018;22(3):683-93. PMID 29392572
86: Ohayon MM, Carskadon MA, Guilleminault C, Vitiello MV. Meta-analysis of quantitative sleep parameters from childhood to old age in healthy individuals: developing normative sleep values across the human lifespan. Sleep 2004;27(7):1255-73. PMID 15586779
87: Ohayon MM, Dauvilliers Y, Reynolds CF. Operational definitions and algorithms for excessive sleepiness in the general population. Arch Gen Psychiatry 2012;69(1):71-9. PMID 22213791
88: Osorio RS, Gumb T, Pirraglia E, et al. Sleep-disordered breathing advances cognitive decline in the elderly. Neurology 2015;84(19):1964-71. PMID 25878183
89: Osorio RS, Pirraglia E, Aguera-Ortiz LF, et al. Greater risk of Alzheimer's disease in older adults with insomnia. J Am Geriatr Soc 2011;59(3):559-62. PMID 21391952
90: Owusu JT, Wennberg AM, Holingue CB, Tzuang M, Abeson KD, Spira AP. Napping characteristics and cognitive performance in older adults. Int J Geriatr Psychiatry 2019;34(1):87-96. PMID 30311961
91: Pallansch J, Li Y, Bena J, Wang L, Foldvary-Schaefer N. Patient-reported outcomes in older adults with obstructive sleep apnea treated with continuous positive airway pressure therapy. J Clin Sleep Med 2018;14(2):215-22. PMID 29351819
92: Polo-Kantola P. Sleep problems in midlife and beyond. Maturitas 2011;68(3):224-32. PMID 21295422
93: Redline S, Punjabi N, Claggett B, et al. Sleep apnea is associated with subclinical myocardial injury in the community: The ARIC-SHHS Study. Am J Respir Crit Care Med 2013;188(12):1460-5. PMID 24156237
94: Richards KC, Gooneratne N, Dicicco B, et al. CPAP adherence may slow 1-year cognitive decline in older adults with mild cognitive impairment and apnea. JAGS 2019;67(3):558-64. PMID 30724333
95: Rocca WA, Petersen RC, Knopman DS, et al. Trends in the incidence and prevalence of Alzheimer's disease, dementia, and cognitive impairment in the United States. Alzheimers Dement 2011;7(1):80-93. PMID 21255746
96: Rodrigues R, Nicholson K, Guaiana G, Wilk P, Stranges S, Anderson KK. Sleep problems and psychological well-being: baseline findings from the Canadian Longitudinal Study on Aging. Can J Aging 2023;42(2):230-40. PMID 36408684
97: Sack RL, Auckley D, Auger RR, et al. Circadian rhythm sleep disorders: part i, basic principles, shift work and jet lag disorders. Sleep 2007;30(11):1460-83. PMID 18041480
98: Scarpelli S, Alfonsi V, Gorgoni M, Camaioni M, Giannini AM, De Gennaro L. Age-related effect of sleepiness on driving performance: a systematic-review. Brain Sci 2021;11(8):1090. PMID 34439709
99: Scholtens RM, van Munster BC, van Kempen MF, de Rooij SE. Physiological melatonin levels in healthy older people: a systematic review. J Psychosom Res 2016;86:20-7. PMID 27302542
100: Shepertycky MR, Banno K, Kryger MH. Differences between men and women in the clinical presentation of patients diagnosed with obstructive sleep apnea syndrome. Sleep 2005;28(3):309-14. PMID 16173651
101: Shi L, Chen SJ, Ma MY, et al. Sleep disturbances increase the risk of dementia: a systematic review and meta-analysis. Sleep Med Rev 2018;40:4-16. PMID 28890168
102: Sindi S, Kareholt I, Johansson L, et al. Sleep disturbances and dementia risk: a multicenter study. Alzheimers Dement 2018;14(10):1235-42. PMID 30030112
103: Sindi S, Pérez LM, Vetrano DL, et al. Sleep disturbances and the speed of multimorbidity development in old age: results from a longitudinal population-based study. BMC Med 2020;18(1):382. PMID 33280611
104: Soysal P, Smith L, Tan SG, Capar E, Veronese N, Yang L. Excessive daytime sleepiness is associated with an increased frequency of falls and sarcopenia. Exp Gerontol 2021;150:111364. PMID 33892131
105: Spira AP, Gamaldo AA, An Y, et al. Self-reported sleep and β-amyloid deposition in community- dwelling older adults. JAMA Neurol 2013;70(12):1537-43. PMID 24145859
106: Sprecher KE, Koscik RL, Carlsson CM, et al. Poor sleep is associated with CSF biomarkers of amyloid pathology in cognitively normal adults. Neurology 2017;89(5):445-53. PMID 28679595
107: Stone KL, Xiao Q. Impact of poor sleep on physical and mental health in older women. Sleep Med Clin 2018;13(3):457-65. PMID 30098759
108: Tasbakan MS, Gunduz C, Pirildar S, Basoglu OK. Quality of life in obstructive sleep apnea is related to female gender and comorbid insomnia. Sleep Breath 2018;22(4):1013-20. PMID 29352360
109: Unruh ML, Redline S, An MW, et al. Subjective and objective sleep quality and aging in the sleep heart health study. J Am Geriatr Soc 2008;56(7):1218-27. PMID 18482295
110: van den Berg JF, Miedema HM, Tulen JH, Hofman A, Neven AK, Tiemeier H. Sex differences in subjective and actigraphic sleep measures: a population-based study of elderly persons. Sleep 2009;32(10):1367-75. PMID 19848365
111: Van Doorn B, Bosch JL. Nocturia in older men. Maturitas 2012;71(1):8-12. PMID 22079871
112: Vaughan CP, Bliwise DL. Sleep and nocturia in older adults. Sleep Med Clin 2018;13(1):107-16. PMID 29412977
113: Virta JJ, Heikkila K, Perola M, et al. Midlife sleep characteristics associated with late life cognitive function. Sleep 2013;36(10):1533-41. PMID 24082313
114: Volicer L, Harper DG, Manning BC, Goldstein R, Satlin A. Sundowning and circadian rhythms in Alzheimer’s disease. Am J Psychiatry 2001;158(5):704-11. PMID 11329390
115: Wai JL, Yu DS. The relationship between sleep-wake disturbances and frailty among older adults: a systematic review. J Adv Nurs 2020;76(1):96-108. PMID 31588595
116: Wittmann M, Dinich J, Merrow M, Roenneberg T. Social jetlag: misalignment of biological and social time. Chronobiol Int 2006;23(1-2):497-509. PMID 16687322
117: Yoon IY, Kripke DF, Youngstedt SD, Elliott JA. Actigraphy suggests age-related differences in napping and nocturnal sleep. J Sleep Res 2003;12(2):87-93. PMID 12753345
118: Zdanys KF, Steffens DC. Sleep disturbances in the elderly. Psychiatr Clin North Am 2015;38(4):723-41 PMID 26600105
119: Zee PC, Vitiello MV. Circadian rhythm sleep disorder: irregular sleep wake rhythm. Sleep Med Clin 2009;4:213-8. PMID 20160950

Contributors

All contributors' financial relationships have been reviewed and mitigated to ensure that this and every other article is free from commercial bias.

Authors

Biancamaria Guarnieri MD

Dr. Guarnieri of the Center of Sleep Medicine Villa Serena Hospital has received honorariums from Fidia Pharma as a speaker and consultant fees from Merck Sharp & Dohme.
See Profile
Ilde Pieroni MSc

Ilde Pieroni of the Sapienza University of Rome has no relevant financial relationships to disclose.
See Profile

Editor

Federica Provini MD

Dr. Provini of the University of Bologna and IRCCS Institute of Neurological Sciences of Bologna received speakers' fees from Idorsia, Italfarmaco, and NeoPharmed Gentili Spa.
See Profile

This is an article preview.
Start a Free Account
to access the full version.

Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com

ISSN: 2831-9125

Sleep and aging

Associated Disorders

nocturia

Differential Diagnosis

circadian sleep-wake rhythm disorders

Also Relevant

Advanced sleep-wake phase disorder
Delayed sleep-wake phase disorder
Hypersomnolence
Insomnia
Irregular sleep-wake rhythm disorder
- Obstructive sleep apnea
- Parasomnias
- Periodic limb movements
- Rapid eye movement sleep behavior disorder
- Restless legs syndrome
- Sleep and dementia

Clinical Categories

Sleep Disorders

Sleep and aging

Sleep and aging

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Clinical vignette

Biological basis

Etiology and pathogenesis

Epidemiology

Prevention

Differential diagnosis

Confusing conditions

Associated or underlying disorders

Diagnostic workup

Management

References

Contributors

Authors

Editor

Patient Profile

This is an article preview.
Start a Free Account
to access the full version.

Questions or Comment?

Also in This Category

Telehealth and cognitive behavioral therapy for insomnia (CBT-I)

NonREM parasomnias

Neurologic disorders associated with obesity

Hypersomnolence

Sleep disorders in women

Sleep, stroke, and vascular dementia

Parasomnia overlap disorder and status dissociatus

Stimulant-dependent sleep disorder

Sleep and aging

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Clinical vignette

Biological basis

Etiology and pathogenesis

Epidemiology

Prevention

Differential diagnosis

Confusing conditions

Associated or underlying disorders

Diagnostic workup

Management

References

Contributors

Authors

Editor

Patient Profile

This is an article preview. Start a Free Account to access the full version.

Questions or Comment?

Also in This Category

Telehealth and cognitive behavioral therapy for insomnia (CBT-I)

NonREM parasomnias

Neurologic disorders associated with obesity

Hypersomnolence

Sleep disorders in women

Sleep, stroke, and vascular dementia

Parasomnia overlap disorder and status dissociatus

Stimulant-dependent sleep disorder

This is an article preview.
Start a Free Account
to access the full version.